N@N

Cubist Pharmaceuticals and the New England Patriots Radio Network Renew Program to Recognize Innovative Science Teachers

^{Published on 2010-08-10 10:10:45 - Market Wire}
 

LEXINGTON, Mass.--([ BUSINESS WIRE ])--[ Cubist Pharmaceuticals, Inc. ] (NASDAQ: CBST) today announced that it is a" for the second year in a row a" teaming up with the New England Patriots Radio Network, 98.5 The Sports Hub, and its 36-station radio network throughout New England, during the 2010 New England Patriots season to recognize innovative science teachers in middle schools and high schools throughout New England.

Throughout the season, Cubist and the New England Patriots Radio Network will recognize science teachers leading the way in the classroom. Each week, during the New England Patriots season, a teacher will be selected as the Cubist Pharmaceuticals aTeacher of the Weeka� and announced during the New England Patriots radio broadcast. Each teacher selected will be qualified to be recognized as the recipient of the Cubist Pharmaceuticals Science Education Leadership Award. The grand prize winning teacher will have a special meet and greet with Patriots broadcasters at the CBS Scene in Foxboro at the last home game of the 2010 season on January 2. Cubist will also present a $500 check to the winning teachera�s school science program. Also, a Patriots alumni player will be making a special appearance at that teachera�s school at the end of the season. Log onto the [ patriotsradionetwork.com ] to enter online.

Cubist President and CEO Michael Bonney said, aCubist is committed, as an organization and through the volunteer work of our employees, to ensuring that todaya�s young people are prepared for careers in science if that is their desire. That preparation is being made possible by a dedicated group of science teachers who are implementing innovative teaching techniques and opening young minds to the endless possibilities that science provides.a

Dr. Susan Windham-Bannister, President & CEO of the Massachusetts Life Sciences Center, said, aThe Massachusetts Life Sciences Center is acutely aware of the need for young people to become interested in science at an early age, and addressing this challenge is a core part of the Centera�s mission. The Commonwealtha�s burgeoning life science industry needs a well educated and dedicated workforce prepared to take on the increasingly technical and scientific careers of the 21^st century here and around the world. That future workforce is being prepared in todaya�s middle and high schools and is dependent on innovative teachers stimulating young minds to pursue science in college. Cubist Pharmaceuticalsa� Science Education Leadership Award celebrates great teachers leading the way.a

About Cubist

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN� (daptomycin for injection), the first antibiotic in a class of anti-infectives called lipopeptides. The Cubist clinical product pipeline currently consists of a Phase 2 program, added with Cubista�s acquisition of Calixa Therapeutics Inc. in December 2009, focused on the development of a novel cephalosporin to address certain serious infections caused by multi-drug resistant (MDR) Gram-negative organisms; a Phase 2 program for the treatment of CDAD (Clostridium difficile-associated diarrhea); and a Phase 1 program intended to address the unmet medical need for a treatment for serious infections caused by MDR Gram-negative pathogens. Cubist is also working on several pre-clinical programs being developed to address areas of significant medical needs. These include an anti-infective program for the treatment of respiratory syncytial virus (RSV) in children, therapies to treat various serious bacterial infections, and agents to treat acute pain. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubista�s web site at [ www.cubist.com ].

Cubist and CUBICIN are registered trademarks of Cubist Pharmaceuticals, Inc.